Filters
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
MMP2 Gene Multicentric osteolysis, nodulosis, and arthropathy NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
MMP2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 110 | 50 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Baylor Genetics United States | 1 | 354 |
|
Skeletal Dysplasias and Disorders Panel CGC Genetics Unilabs Portugal | 1 | 606 |
|
Multicentric osteolysis, nodulosis and arthropathy (sequence analysis of MMP2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Mendelics Brazil | 1 | 333 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 643 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
NewbornDx Advanced Sequencing Evaluation Athena Diagnostics United States | 1 | 1722 |
|
Osteogenesis Imperfecta and Decreased Bone Density NGS Panel Fulgent Genetics United States | 111 | 32 |
|
Multicentric Osteolysis, Nodulosis, And Arthropathy (MMP2 Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel Blueprint Genetics Finland | 2 | 308 |
|
Multicentric Osteolysis Nodulosis and Arthropathy: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Comprehensive Skeletal Dysplasias and Disorders Panel Blueprint Genetics Finland | 1 | 246 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 543 | 178 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.